CHINOOK THERAPEUTICS, INC. Annual Net Income (Loss) Attributable to Parent in USD from 2013 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Chinook Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2013 to 2022.
  • Chinook Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$66.9M, a 77.8% decline year-over-year.
  • Chinook Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$246M, a 166% decline year-over-year.
  • Chinook Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$188M, a 82.5% decline from 2021.
  • Chinook Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$103M, a 26.1% decline from 2020.
  • Chinook Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$81.6M, a 75.5% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.